Autolus Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $10,091 | $1,775 | $406 |
Gross Profit | -1,895 | 8,285 | 24 | |
EBITDA | -56,620 | -36,951 | -39,111 | -44,014 |
EBIT | -58,515 | -38,757 | -40,886 | -45,393 |
Net Income | -58,272 | -52,690 | -77,171 | -45,849 |
Net Change In Cash | 0 | 10,091 | 1,775 | 406 |
Free Cash Flow | -51,923 | -41,046 | -26,309 | -41,686 |
Cash | 706,959 | 759,544 | 239,566 | 256,415 |
Basic Shares | 266,025 | 222,170 | 174,029 | 173,984 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,698 | $6,194 | $2,330 | $242 |
Gross Profit | -4,867 | -131,026 | -126,321 | -134,646 |
EBITDA | -188,463 | -156,363 | -155,749 | -162,487 |
EBIT | -195,028 | -163,785 | -164,297 | -168,236 |
Net Income | -208,383 | -148,839 | -142,096 | -142,094 |
Net Change In Cash | 1,698 | 6,194 | 2,330 | 242 |
Free Cash Flow | -156,573 | -123,149 | -126,718 | -132,439 |
Cash | 239,566 | 382,436 | 310,338 | 153,299 |
Basic Shares | 173,941 | 94,993 | 72,084 | 51,558 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.22 |
2024-03-31 | -$0.24 |
2023-12-31 | -$0.45 |
2023-09-30 | -$0.26 |
